|
Weitz & Luxenberg is no longer accepting Heparin cases
FDA Alert: Baxter recalls blood-thinner Drug, Heparin
Get a free legal
review of your case
Baxter Issues Urgent Nationwide Voluntary Drug Recall of Heparin 1,000
Units/ml 10 and 30ml Multi-Dose Vials
NDC NUMBERS: 0641-2440-45,
0641-2440-41, 0641-2450-45 and 0641-2450-41; LOTS: 107054, 117085, 047056,
097081, 107024, 107064, 107066, 107074, 107111
January 25, 2008 – Baxter Healthcare Corporation has announced the voluntary recall of nine lots of the drug heparin sodium injection 1000 units/mL 10mL and 30mL multi-dose vials. The company began recalling the lots on January 17, 2008 as a precautionary measure due to an increase in the number of reports of adverse patient reactions that may be associated with the product. Baxter is conducting a thorough investigation of these reports to identify the cause of the increase in allergic-type reactions.
Adverse patient reactions have included: stomach pain or discomfort, nausea, vomiting, diarrhea, decreased or low blood pressure, chest pain, fast heart rate, dizziness, fainting, unresponsiveness, shortness of breath, feeling your heart beat strong or fast, drug ineffectiveness, burning sensation, redness or paleness of skin, abnormal sensation of the skin, mouth or lips, flushing, increased sweating, decreased skin sensitivity, headache, feeling unwell, restlessness, watery eyes, throat swelling, thirst and difficulty opening the mouth. Some of these reactions may be severe or life threatening.
Heparin is a prescription, injectable blood anticoagulant (also called a
blood thinner). The 1,000 units/mL multi-dose vials are primarily used for
hemodialysis and cardiac invasive procedures. To date, the company has not
observed a significant increase in adverse event reports occurring with any
other of its heparin presentations.
Customers have been instructed to
discontinue use and segregate the recalled product from the rest of their
inventory. Customers should then contact Baxter to arrange for return and
replacement product. Customers with recalled product purchased indirectly should
contact their wholesaler or distributor for return and replacement product.
Customers with questions may contact Baxter at 1-800-667-0959. Representatives
are available Monday through Friday from 7 a.m. to 6 p.m. CT.
Baxter
International Inc. through its subsidiaries, assists healthcare professionals
and their patients with the treatment of complex medical conditions, including
cancer, hemophilia, immune disorders, kidney disease and trauma. The company
applies its expertise in medical devices, pharmaceuticals and biotechnology to
make a meaningful difference in patients' lives. For more information about
Baxter, visit www.baxter.com.
If you were harmed after being administered
heparin, please complete the form below and a representative of our firm will
contact you as soon as possible.
see also:
Heparin production
Learn about Heparin productionFREE legal review and Information about Heparin production
Heparin & Pig Enzyme
Enzymes from pig lining are used to manufacture Heparin.Did you know that pig enzymes are an ingredient in Heparin?
FDA Health Advisory
FDA Issues Advisory on Heparin Due to Health Risks--Free Lawsuit InfoDid You Suffer Adverse Reaction After Heparin Injection? Lawsuit info
